20 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 31406237 | Human H1 receptor (HRH1) gene polymorphism is associated with the severity of side effects after desloratadine treatment in Chinese patients with chronic spontaneous uticaria. | 2020 Feb | 4 |
2 | 32406319 | Desloratadine, a Novel Antigrowth Reagent for Bladder Cancer. | 2020 Jan-Dec | 1 |
3 | 30863716 | Quantum chemical calculation and binding modes of H1R; a combined study of molecular docking and DFT for suggesting therapeutically potent H1R antagonist. | 2019 | 1 |
4 | 31274307 | Route to Prolonged Residence Time at the Histamine H1 Receptor: Growing from Desloratadine to Rupatadine. | 2019 Jul 25 | 4 |
5 | 19236123 | Examining the tolerability of the non-sedating antihistamine desloratadine: a prescription-event monitoring study in England. | 2009 | 1 |
6 | 17298105 | Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial. | 2007 | 1 |
7 | 17577463 | Effectiveness of desloratadine 5 mg once daily in patients with symptoms of seasonal allergic rhinitis: results of a Canadian multicenter, open-label trial. | 2007 Mar | 1 |
8 | 17906161 | Multiple-dose pharmacokinetics and safety of desloratadine in subjects with moderate hepatic impairment. | 2007 Oct | 1 |
9 | 16970513 | Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England. | 2006 | 1 |
10 | 16259582 | Review of desloratadine for the treatment of allergic rhinitis, chronic idiopathic urticaria and allergic inflammatory disorders. | 2005 Nov | 1 |
11 | 17523764 | Predicting and establishing the clinical efficacy of a histamine h(1)-receptor antagonist : desloratadine, the model paradigm. | 2005 | 1 |
12 | 15168099 | Effects of desloratadine, diphenhydramine, and placebo on driving performance and psychomotor performance measurements. | 2004 Jul | 1 |
13 | 15564772 | Desloratadine inhibits constitutive and histamine-stimulated nuclear factor-kappaB activity consistent with inverse agonism at the histamine H1 Receptor. | 2004 Dec | 2 |
14 | 12962522 | Desloratadine: an update of its efficacy in the management of allergic disorders. | 2003 | 1 |
15 | 12167464 | Biochemical characterization of desloratadine, a potent antagonist of the human histamine H(1) receptor. | 2002 Aug 9 | 6 |
16 | 12492724 | Therapeutic points of intervention and clinical implications: role of desloratadine. | 2002 | 1 |
17 | 12492727 | Advances in allergy management. | 2002 | 2 |
18 | 11243501 | Desloratadine activity in concurrent seasonal allergic rhinitis and asthma. | 2001 | 2 |
19 | 12768222 | Desloratadine: A preclinical and clinical overview. | 2001 Apr | 1 |
20 | 11080746 | Therapeutic options in allergic disease: antihistamines as systemic antiallergic agents. | 2000 Nov | 1 |